Reports for HYDROCHLOROTHIAZIDE
Ingredient
HYDROCHLOROTHIAZIDE
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MINT-IRBESARTAN/HCTZ | 12.5MG 300.0MG | TABLET | Resolved | 2019-01-03 | 2019-01-16 | 71060 |
MINT-IRBESARTAN/HCTZ | 12.5MG 300.0MG | TABLET | Resolved | 2019-01-16 | 2021-08-11 | 72666 |
MINT-IRBESARTAN/HCTZ | 25.0MG 300.0MG | TABLET | Resolved | 2019-04-08 | 2021-08-11 | 80797 |
JAMP-LOSARTAN HCTZ | 12.5MG 50MG | TABLET | Resolved | 2017-09-29 | 2018-05-19 | 23901 |
JAMP-LOSARTAN HCTZ | 12.5MG 50MG | TABLET | Resolved | 2017-09-29 | 2018-05-19 | 23908 |
JAMP-LOSARTAN HCTZ | 12.5MG 50MG | TABLET | Resolved | 2019-10-07 | 2022-09-09 | 95707 |
JAMP-LOSARTAN HCTZ | 12.5MG 50MG | TABLET | Resolved | 2019-10-07 | 2022-09-09 | 95713 |
JAMP-LOSARTAN HCTZ | 25MG 100MG | TABLET | Resolved | 2017-09-29 | 2018-05-02 | 23905 |
JAMP-LOSARTAN HCTZ | 25MG 100MG | TABLET | Resolved | 2017-09-29 | 2018-05-19 | 23918 |
JAMP-LOSARTAN HCTZ | 25MG 100MG | TABLET | Resolved | 2019-10-07 | 2022-09-09 | 95704 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65050 | ||
ACT CANDESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65052 | ||
ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65068 | ||
ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65071 | ||
ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65074 | ||
RAMIPRIL-HCTZ | Discontinued | 2018-12-21 | 2018-12-22 | 70392 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 |